Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 451, 1066-1067 (28 February 2008) | doi:10.1038/4511066a; Published online 27 February 2008
Open Innovation Challenges
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
-
Fast Growth of Transformed Soybean Shoots
A method for accelerating growth of soybean shoots is desired.
- More Challenges
- Powered by:
nature jobs
Team Leader for Analytical Development
- Novo Nordisk
- Bagsværd, Denmark
Sensory Scientist
- Philip Morris International (PMI)
- Neuchatel, Switzerland
Cancer: Crossing over to drug resistance
David M. Livingston1 & Daniel P. Silver1
Abstract
Certain cancers stem from mutations that prevent a cell from repairing its damaged DNA efficiently. But antitumour chemotherapy that exploits that repair defect can in turn be nullified by counter-mutation.
Two papers1, 2 in this issue provide insight into a subset of breast and ovarian cancers, the action of drugs used to treat them, and a novel mechanism of chemotherapeutic drug resistance. The papers are by Edwards et al.1 and Sakai et al.2, and appear on pages 1111 and 1116.
- David M. Livingston and Daniel P. Silver are at the Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA.
Email: david_livingston@dfci.harvard.edu
Email: daniel_silver@dfci.harvard.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Bench to bedside BRCA: From therapeutic target to therapeutic shieldNature Medicine News and Views (01 May 2008)
RESEARCH
A catalytic DNA for porphyrin metallationNature Structural Biology Correspondence (01 Sep 1996)
DNA is bound within the central hole to one or two of the six subunits of the T7 DNA helicaseNature Structural Biology Correspondence (01 Sep 1996)
